These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 24241157)

  • 1. Management and treatment goals in Polish patients with type 2 diabetes of short duration: results of the ARETAEUS2-Grupa study.
    Bała MM; Płaczkiewicz-Jankowska E; Leśniak W; Topór-Mądry R; Michałejko M; Jankowski M; Strzeszyński L; Sieradzki J; Czupryniak L;
    Pol Arch Med Wewn; 2013; 123(11):573-81. PubMed ID: 24241157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular risk management in type 2 diabetes of more than 10-year duration: Results of Polish ARETAEUS2-Grupa Study.
    Leśniak W; Bała MM; Płaczkiewicz-Jankowska E; Topór-Mądry R; Jankowski M; Sieradzki J; Banasiak W;
    Cardiol J; 2015; 22(2):150-9. PubMed ID: 25299503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management and treatment goals in Polish patients with type 2 diabetes of more than ten years' duration - results of ARETAEUS2-Grupa Study.
    Bała MM; Płaczkiewicz-Jankowska E; Leśniak W; Topór-Mądry R; Jankowski M; Grzeszczak W; Sieradzki J;
    Endokrynol Pol; 2014; 65(3):158-68. PubMed ID: 24971915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is newly diagnosed type 2 diabetes treated according to the guidelines? Results of the Polish ARETAEUS1 study.
    Bała MM; Płaczkiewicz-Jankowska E; Topór-Mądry R; Leśniak W; Jaeschke R; Sieradzki J; Grzeszczak W; Banasiak W;
    Pol Arch Med Wewn; 2011; 121(1-2):7-17. PubMed ID: 21346692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diabetes control in type 2 diabetic subjects treated in primary health care--how far is from life to standards?].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2008; 65(6):277-82. PubMed ID: 18853658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular risk factors control in Polish patients with type 2 diabetes within the first two years of diagnosis: results of the ARETAEUS1 study.
    Bała MM; Leśniak W; Płaczkiewicz-Jankowska E; Topór-Mądry R; Jaeschke R; Sieradzki J; Grzeszczak W; Banasiak W;
    Kardiol Pol; 2011; 69(12):1249-57. PubMed ID: 22219100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment Patterns in Patients With Newly Diagnosed Type 2 Diabetes in China: A Retrospective, Longitudinal Database Study.
    Wang C; Gao Y; Zhu L; Huang M; Wu Y; Xuan J
    Clin Ther; 2019 Aug; 41(8):1440-1452. PubMed ID: 31155146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of diabetes care in Slovenia, Croatia, Serbia, Bulgaria and Romania : An observational, non-interventional, cross-sectional study.
    Cokolic M; Lalic NM; Micic D; Mirosevic G; Klobucar Majanovic S; Lefterov IN; Graur M
    Wien Klin Wochenschr; 2017 Mar; 129(5-6):192-200. PubMed ID: 27933508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diabetes control in type 2 diabetic subjects treated in primary health care].
    Fabian W; Majkowska L; Moleda P; Stefański A
    Pol Arch Med Wewn; 2006 Aug; 116(2):760-5. PubMed ID: 17424921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescribing Paradigm Shift? Applying the 2019 European Society of Cardiology-Led Guidelines on Diabetes, Prediabetes, and Cardiovascular Disease to Assess Eligibility for Sodium-Glucose Cotransporter 2 Inhibitors or Glucagon-Like Peptide 1 Receptor Agonists as First-Line Monotherapy (or Add-on to Metformin Monotherapy) in Type 2 Diabetes in Scotland.
    Caparrotta TM; Blackbourn LAK; McGurnaghan SJ; Chalmers J; Lindsay R; McCrimmon R; McKnight J; Wild S; Petrie JR; Philip S; McKeigue PM; Webb DJ; Sattar N; Colhoun HM;
    Diabetes Care; 2020 Sep; 43(9):2034-2041. PubMed ID: 32581068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of patients with type 2 diabetes of short duration in Poland: Rationale, design and preliminary results of the ARETAEUS1 study.
    Bała MM; Płaczkiewicz-Jankowska E; Topór-Madry R; Leśniak W; Wiercińska E; Szczepaniak P; Jaeschke R; Sieradzki J; Grzeszczak W; Banasiak W;
    Pol Arch Med Wewn; 2009 Sep; 119(9):533-40. PubMed ID: 19776697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treat-to-target HbA
    Gagliardino JJ; Elgart J; Forti L; Guaita MS; Chantelot JM
    Diabetes Metab Res Rev; 2019 Sep; 35(6):e3166. PubMed ID: 30963685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of poorly controlled Type 2 diabetes patients in Swiss primary care.
    Frei A; Herzog S; Woitzek K; Held U; Senn O; Rosemann T; Chmiel C
    Cardiovasc Diabetol; 2012 Jun; 11():70. PubMed ID: 22704274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical care of type 2 diabetes mellitus in light of international and national recommendations: a retrospective analysis.
    Burgmann K; Fatio S; Jordi B; Rutishauser J
    Swiss Med Wkly; 2013; 143():w13871. PubMed ID: 24163110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to national diabetes guidelines through monitoring quality indicators--A comparison of three types of care for the elderly with special emphasis on HbA1c.
    Neumark AS; Brudin L; Neumark T
    Prim Care Diabetes; 2015 Aug; 9(4):253-60. PubMed ID: 25865853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of anti-diabetic medication use in patients with type 2 diabetes mellitus in England and Wales.
    Datta-Nemdharry P; Thomson A; Beynon J; Donegan K
    Pharmacoepidemiol Drug Saf; 2017 Feb; 26(2):127-135. PubMed ID: 27642000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disparity in Guideline-Based Antidiabetic Drugs Prescribing for Type 2 Diabetes Patients in Primary Healthcare Facilities Across China, 2017-2019.
    Fu M; Gong Z; Zhu Y; Li C; Li H; Shi L; Guan X
    Pharmacoepidemiol Drug Saf; 2024 Aug; 33(8):e5882. PubMed ID: 39092465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in Screening Practices for Prediabetes and Diabetes Since the Recommendation for Hemoglobin A
    Evron JM; Herman WH; McEwen LN
    Diabetes Care; 2019 Apr; 42(4):576-584. PubMed ID: 30728220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing variability in compliance with recommendations given by the International Diabetes Federation (IDF) for patients with type 2 diabetes in primary care using electronic records. The APNA study.
    Brugos-Larumbe A; Aldaz-Herce P; Guillen-Grima F; Garjón-Parra FJ; Bartolomé-Resano FJ; Arizaleta-Beloqui MT; Pérez-Ciordia I; Fernández-Navascués AM; Lerena-Rivas MJ; Berjón-Reyero J; Jusué-Rípodas L; Aguinaga-Ontoso I
    Prim Care Diabetes; 2018 Feb; 12(1):34-44. PubMed ID: 28732655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Greek registry of current type 2 diabetes management, aiming to determine core clinical approaches, patterns and strategies.
    Liatis S; Iraklianou S; Kazakos K; Mastorakos G; Milios K; Mouslech Z; Noutsou M; Pagkalos E; Sampanis C;
    BMC Endocr Disord; 2019 Apr; 19(1):39. PubMed ID: 31023374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.